4. Shakoori A, Fujii G, Yoshimura S, et al. Identification of a five-pass transmembrane protein family localizing in the Golgi apparatus and the ER. Biochem Biophys Res Commun 2003; 312:850–7.
https://doi.org/10.1016/j.bbrc.2003.10.197
5. Soonthornsit J, Sakai N, Sasaki Y, Watanabe R, Osako S, Nakamura N. YIPF1, YIPF2, and YIPF6 are
medial-/
trans-Golgi and
trans-Golgi network-localized Yip domain family proteins, which play a role in the Golgi reassembly and glycan synthesis. Exp Cell Res 2017; 353:100–8.
https://doi.org/10.1016/j.yexcr.2017.03.011
6. Tanimoto K, Suzuki K, Jokitalo E, et al. Characterization of YIPF3 and YIPF4, cis-Golgi Localizing Yip domain family proteins. Cell Struct Funct 2011; 36:171–85.
https://doi.org/10.1247/csf.11002
7. Barrowman J, Wang W, Zhang Y, Ferro-Novick S. The Yip1p.Yif1p complex is required for the fusion competence of endoplasmic reticulum-derived vesicles. J Biol Chem 2003; 278:19878–84.
https://doi.org/10.1074/jbc.M302406200
9. Prost S, LeDiscorde M, Haddad R, Gluckman JC, Canque B, Kirszenbaum M. Characterization of a novel hematopoietic marker expressed from early embryonic hematopoietic stem cells to adult mature lineages. Blood Cells Mol Dis 2002; 29:236–48.
https://doi.org/10.1006/bcmd.2002.0563
12. Zhao S, Zhu M, Chen H. Immunogenomics for identification of disease resistance genes in pigs: a review focusing on Gram-negative
bacilli. J Anim Sci Biotechnol 2012; 3:34
https://doi.org/10.1186/2049-1891-3-34
13. Tamassia N, Le Moigne V, Rossato M, et al. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J Immunol 2008; 181:6563–73.
https://doi.org/10.4049/jimmunol.181.9.6563
19. Reimer T, Brcic M, Schweizer M, Jungi TW. poly(I:C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages. J Leukoc Biol 2008; 83:1249–57.
https://doi.org/10.1189/jlb.0607412
21. Dwyer J, Li H, Xu D, Liu JP. Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann NY Acad Sci 2007; 1114:36–47.
https://doi.org/10.1196/annals.1396.022
23. Zhang G, Zhang L, Yang X, et al. High
ETS2 expression predicts poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Ann Hematol 2019; 98:519–25.
https://doi.org/10.1007/s00277-018-3440-4
24. Zhang GW, Tian X, Li Y, Wang ZQ, Li XD, Zhu CY. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway. Biomed Pharmacother 2018; 104:119–26.
https://doi.org/10.1016/j.biopha.2018.05.029
25. Roussel-Gervais A, Naciri I, Kirsh O, et al. Loss of the Methyl-CpG-binding protein ZBTB4 alters mitotic checkpoint, increases aneuploidy, and promotes tumorigenesis. Cancer Res 2017; 77:62–73.
https://doi.org/10.1158/0008-5472.CAN-16-1181
27. Yu Y, Shang R, Chen Y, et al. Tumor suppressive ZBTB4 inhibits cell growth by regulating cell cycle progression and apoptosis in Ewing sarcoma. Biomed Pharmacother 2018; 100:108–15.
https://doi.org/10.1016/j.biopha.2018.01.132
29. Nylen C, Aoi W, Abdelmoez AM, et al.
IL6 and
LIF mRNA expression in skeletal muscle is regulated by AMPK and the transcription factors
NFYC,
ZBTB14, and
SP1. Am J Physiol Endocrinol Metab 2018; 315:E995–1004.
https://doi.org/10.1152/ajpendo.00398.2017